Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Southern XP IP Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (92)
Prescription medicine registration (7)
Cancellation by sponsor (2)

Date

2024 (10)
2023 (17)
2022 (8)
2021 (3)
2020 (3)
2019 (22)
2017 (12)
2014 (2)
2013 (12)
2011 (2)
2010 (4)
2008 (2)
2007 (2)
2005 (1)
2001 (1)

Results for "[search-keyword]"

Search

Sponsor content

101 result(s) found, displaying 41 to 50

MIDODRINE SCP midodrine hydrochloride 2.5 mg immediate release tablet blister pack (309179)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MIDODRINE SCP midodrine hydrochloride 2.5 mg immediate release tablet blister pack.
MIDODRINE SCP midodrine hydrochloride 5 mg immediate release tablet blister pack (309180)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MIDODRINE SCP midodrine hydrochloride 5 mg immediate release tablet blister pack.
MIDODRINE ANS midodrine hydrochloride 2.5 mg immediate release tablet blister pack (309181)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MIDODRINE ANS midodrine hydrochloride 2.5 mg immediate release tablet blister pack.
MIDODRINE ANS midodrine hydrochloride 5 mg immediate release tablet blister pack (309182)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MIDODRINE ANS midodrine hydrochloride 5 mg immediate release tablet blister pack.
VASODRINE midodrine hydrochloride 2.5 mg immediate release tablet blister pack (309183)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VASODRINE midodrine hydrochloride 2.5 mg immediate release tablet blister pack.
VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack (309184)

18 December 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VASODRINE midodrine hydrochloride 5 mg immediate release tablet blister pack.
DEFERASIROX TLB, DEFERASIROX SIP, DEFERASIROX ANS (Southern XP IP Pty Ltd)

1 July 2021

Prescription medicine registration

Active ingredients: deferasirox.
CEFUROXIME ANS cefuroxime (as sodium) 750 mg powder for injection vial (310372)

14 November 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CEFUROXIME ANS cefuroxime (as sodium) 750 mg powder for injection vial.
CEFUROXIME SXP cefuroxime (as sodium) 750 mg powder for injection vial (310373)

14 November 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CEFUROXIME SXP cefuroxime (as sodium) 750 mg powder for injection vial.
CEFUROXIME ANS cefuroxime (as sodium) 1500 mg powder for injection vial (310374)

14 November 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CEFUROXIME ANS cefuroxime (as sodium) 1500 mg powder for injection vial.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.